“…2,3 Despite these drawbacks, leadless TPSs have been used in carefully selected pediatric patients, often motivated by limited venous access, risk factors for endovascular infection, and/or anticipated time-limited pacing need. [4][5][6][7][8][9] In this issue of The Journal of Innovations in Cardiac Rhythm Management, Hackett et al report the implantation of a Micra™ VR TPS in a 28 kg, nine-yearold patient by surgical cutdown of the right internal jugular vein.…”